Home/Pipeline/SurTract™ Safety Syringe with SafeR®

SurTract™ Safety Syringe with SafeR®

Needlestick Injury Prevention

Commercial LaunchLaunched (Jan 2026)N/A

Key Facts

Indication
Needlestick Injury Prevention
Phase
Commercial Launch
Status
Launched (Jan 2026)
Company

About Terumo Medical

Terumo Medical Corporation (TMC) is a fully integrated, revenue-generating subsidiary of the publicly traded Terumo Corporation (TSE: 4543), operating as a key driver of the group's North American and global business. With a mission to contribute to society through healthcare, TMC has achieved a leading position across multiple medical device domains, including vascular intervention, drug delivery systems, and contract development services. Its strategy is built on a diversified, multi-platform approach that spans proprietary R&D, manufacturing, and direct sales, mitigating reliance on any single technology while addressing broad needs across the healthcare continuum from acute intervention to daily clinical care.

View full company profile

Other Needlestick Injury Prevention Drugs

DrugCompanyPhase
Protectus Safety SyringeProtectus Medical DeviceApproved